Trials / Conditions / Hormone Receptor Negative Breast Cancer

Hormone Receptor Negative Breast Cancer

3 registered clinical trials studyying Hormone Receptor Negative Breast Cancer — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advan NCT06805812	Fondazione IRCCS Istituto Nazionale dei Tumori, Milano	—
Terminated	BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT) NCT04296942	National Cancer Institute (NCI)	Phase 1
Completed	CDK4/6-inhibitor or Chemotherapy, in Combination with ENDOcrine Therapy, for Advanced Breast Cancer / KENDO NCT03227328	Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS	Phase 2